Fasoracetam

Fasoracetam (NS 105) is the activator of metabotropic glutamate receptor (mGluR) . Fasoracetam (NS 105) has the potential for the research of attention-deficit hyperactivity disorder (ADHD) and Alzheimer's disease (AD) [1][2].

Product Specifications

CAS Number

[110958-19-5]

Product Name Alternative

NS 105

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

MGluR

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/fasoracetam.html

Purity

99.41

Solubility

DMSO : 250 mg/mL (ultrasonic)

Smiles

O=C([C@@H]1NC(CC1)=O)N2CCCCC2

Molecular Formula

C10H16N2O2

Molecular Weight

196.25

Precautions

H302, H315, H319, H335

References & Citations

[1]Elia J, et al. Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling. Nat Commun. 2018;9 (1) :4.